Saturday, July 11, 2026

pharma · Transfusion Dependent Beta-Thalassaemia · Labor Induction

Guangzhou Virotech Pharmaceutical

Guangzhou Virotech Pharmaceutical trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
2
Patents
0
Intelligence · Clinical Trials

Guangzhou Virotech Pharmaceutical clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Guangzhou Virotech Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.

Guangzhou Virotech Pharmaceutical trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Guangzhou Virotech Pharmaceutical.

  1. ET-01 — Unknown

    Clinical update
  2. Induction of labor with PGE2 — Approved

    Clinical update

Trial registry

2 studies